Guardian Pharmacy Services GRDN Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Guardian Pharmacy Services in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Guardian Pharmacy Services’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Guardian Pharmacy Services's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Guardian Pharmacy Services's noncontrolling interests in subsidiaries?
- Guardian Pharmacy Services (GRDN) reported noncontrolling interests in subsidiaries of $11.53M in Q1 2026.
- How has Guardian Pharmacy Services's noncontrolling interests in subsidiaries changed year-over-year?
- Guardian Pharmacy Services's noncontrolling interests in subsidiaries increased by 61.8% year-over-year, from $7.13M to $11.53M.
- What is the long-term trend for Guardian Pharmacy Services's noncontrolling interests in subsidiaries?
- Over 2 years (2023 to 2025), Guardian Pharmacy Services's noncontrolling interests in subsidiaries has grown at a -38.0% compound annual growth rate (CAGR), from $31.65M to $12.17M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.